Lamotrigine
Who holds supplier records for Lamotrigine? 30 organisations hold a current record for Lamotrigine: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 19 of them hold a valid EU Certificate of Suitability (20 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (19), China (2), Spain (2), Netherlands (1) and 3 other countries (3); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Lamotrigine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lamotrigine
Reading the evidence
- 30 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
19 of the 27 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 17 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Lamotrigine expires 14 Feb 2045. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (30)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Lamotrigine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Iol Chemicals And Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 36531, 26627 · latest filing Dec 2021
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 18732 · latest filing Sept 2005
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 19908 · latest filing Oct 2006
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 18421 · latest filing Jun 2005
- COHANCE LIFESCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 16259, 23251 · latest filing Nov 2009
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 16142 · latest filing Sept 2002
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 17740 · latest filing Oct 2004
- SMS Pharmaceuticals limitedIndiaCEP Company GMP cert on recordActive DMF 34290 · latest filing Nov 2019
- TAPI NL BVNetherlandsCEPActive DMF 15924 · latest filing Apr 2002
- Torrent PharmaceuticalsIndiaCEP Company GMP cert on recordActive DMF 20289 · latest filing Feb 2007
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 20835 · latest filing Sept 2007
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 23262 · latest filing Oct 2009
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 18090 · latest filing Feb 2005
- CTX LIFE SCIENCES PVT LTDIndiaActive DMF 24958 · latest filing Jun 2011
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 16480 · latest filing Mar 2003
- EMNAR PHARMA PRIVATE LTDIndiaActive DMF 44143 · latest filing May 2026
- Lupin LimitedIndia Company GMP cert on recordActive DMF 19892 · latest filing Oct 2006
- MEDICHEM SASpain Company GMP cert on recordActive DMF 17231 · latest filing Mar 2004
- SYN-TECH CHEM AND PHARM CO LTDTaiwanActive DMF 30270 · latest filing Feb 2016
- SYNTHEXIM CALAIRE CHIMIEActive DMF 23740 · latest filing Apr 2010
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 18960 · latest filing Nov 2005
- UNIMARK REMEDIES LTDIndiaActive DMF 22813 · latest filing May 2009
- Zakłady Farmaceutyczne Polpharma S.A.Poland Company GMP cert on recordActive DMF 20548 · latest filing May 2007
- ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO LTDActive DMF 19541 · latest filing Jun 2006
- IndiaCEP
- IndiaCEP
- IndiaCEP Company GMP cert on record
- PHARMACEUTICAL WORKS POLPHARMA SACEP
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)SpainCEPInactive DMF 18439 · latest filing Jun 2005
- Zhejiang Supor Pharmaceuticals Co., LtdChinaCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (20)
Certificates of Suitability on the EDQM register for Lamotrigine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 24 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SMS PHARMACEUTICALS LIMITED Hyderabad | IN | CEP 2020-222 - Rev 02 Lamotrigine | Nov 2026 | — |
| COHANCE LIFESCIENCES LIMITED Mumbai | IN | CEP 2008-261 - Rev 03 Lamotrigine | Jul 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2009-157 - Rev 04 Lamotrigine | May 2026 | — |
| IOL CHEMICALS AND PHARMACEUTICALS LIMITED Ludhiana | IN | CEP 2013-066 - Rev 02 Lamotrigine | Apr 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2011-010 - Rev 06 Lamotrigine | Feb 2026 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2018-295 - Rev 04 Lamotrigine, Anhydrous Form | Jan 2026 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2018-293 - Rev 01 Lamotrigine | Dec 2025 | — |
| CTX LIFESCIENCES PVT. LIMITED Surat | IN | CEP 2011-168 - Rev 03 Lamotrigine | Dec 2025 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2010-208 - Rev 03 Lamotrigine, Micronised and non-micronised | Oct 2025 | Inspected May 2026 Italy |
| JUBILANT BIOSYS LIMITED Nanjangud | IN | CEP 2009-162 - Rev 03 Lamotrigine | Sept 2025 | — |
| ARAGEN LIFE SCIENCES LIMITED Hyderabad | IN | CEP 2010-249 - Rev 07 Lamotrigine | Jul 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2011-178 - Rev 04 Lamotrigine | Mar 2025 | — |
| TORRENT PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2022-486 - Rev 00 Lamotrigine, Micronised | Nov 2024 | — |
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2009-376 - Rev 01 Lamotrigine | Nov 2024 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2010-212 - Rev 02 Lamotrigine | Mar 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2008-010 - Rev 05 Lamotrigine | Jan 2024 | — |
| PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski | PL | R1-CEP 2010-128 - Rev 02 Lamotrigine | Feb 2023 | — |
| COHANCE LIFESCIENCES LIMITED Hyderabad | IN | R0-CEP 2022-417 - Rev 00 Lamotrigine, Unit-II | Dec 2022 | — |
| Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona | ES | R1-CEP 2010-382 - Rev 04 Lamotrigine | Oct 2022 | — |
| ZHEJIANG SUPOR PHARMACEUTICALS CO., LTD. Shaoxing | CN | R0-CEP 2020-249 - Rev 00 Lamotrigine | Mar 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Lamotrigine are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- WATERSTONE PHARMACEUTICALS HUBEI TIANMEN CO LTDInactive DMF 25775 · filed Dec 2011
- SEQUEL PHARMACHEM PRIVATE LTDInactive DMF 22656 · filed Mar 2009
- India · Inactive DMF 21390 · filed Mar 2008
- Italy · Inactive DMF 21105 · filed Nov 2007
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 20129 · filed Jan 2007
- India · Inactive DMF 18356 · filed May 2005
- Hungary · Inactive DMF 18353 · filed May 2005
- CF PHARMA LTDInactive DMF 18137 · filed Mar 2005
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (164 listed products contain Lamotrigine). The latest listed patent expires 14 Feb 2045. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Lamotrigine is an anticonvulsant medication used primarily to treat epilepsy and bipolar disorder. It works by stabilizing electrical activity in the brain to reduce seizures and mood swings.
Chemical identity
- IUPAC name
- 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
- Canonical SMILES
- C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
- InChIKey
- PYZRQGJRPPTADH-UHFFFAOYSA-N
- Synonyms
- Lamictal API, bw 430c, bw-430c, lamictal, nsc-759171, subvenite
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Anti-epileptic Agent; Mood Stabilizer
- Mechanism of action
- Dihydrofolate Reductase Inhibitors; Organic Cation Transporter 2 Inhibitors
- Physiologic effect
- Decreased Central Nervous System Disorganized Electrical Activity
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Lamotrigine?
30 organisations hold an active US FDA Type II Drug Master File or a CEP for Lamotrigine: Iol Chemicals And Pharmaceuticals Limited (India), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), COHANCE LIFESCIENCES LTD (India), JUBILANT BIOSYS LTD (India), MATRIX PHARMACORP PRIVATE LTD (India) and SMS Pharmaceuticals limited (India), and 22 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Lamotrigine Drug Master Files are active?
Iol Chemicals And Pharmaceuticals Limited (DMF 36531, 26627), Alembic Pharmaceuticals Limited (DMF 18732), APITORIA PHARMA PRIVATE LTD (DMF 19908), Cipla Limited (DMF 18421), COHANCE LIFESCIENCES LTD (DMF 16259, 23251), JUBILANT BIOSYS LTD (DMF 16142), MATRIX PHARMACORP PRIVATE LTD (DMF 17740) and SMS Pharmaceuticals limited (DMF 34290) and 16 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Lamotrigine records mean?
8 organisations have only inactive Type II DMFs for Lamotrigine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Lamotrigine have a European Certificate of Suitability?
Yes. 19 organisations hold a valid CEP for Lamotrigine on the EDQM register, including SMS PHARMACEUTICALS LIMITED Hyderabad (IN), COHANCE LIFESCIENCES LIMITED Mumbai (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), IOL CHEMICALS AND PHARMACEUTICALS LIMITED Ludhiana (IN), ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN) and ZYDUS LIFESCIENCES LIMITED Vadodara (IN) and 14 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Lamotrigine?
Yes. The latest patent listed for an approved US product containing Lamotrigine expires 14 Feb 2045, across 164 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Lamotrigine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Lamotrigine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.